Effects of erdosteine on cyclosporin-A-induced nephrotoxicity

Human and Experimental Toxicology

Volumn 31, Issue 6, 2012, Pages 565-573

  Tutanc, M ^a   Arica, V ^a   Yilmaz, N ^a   Nacar, A ^a   Zararsiz, I ^a   Basarslan, F ^a   Tutanc, O D ^b   Nacar, E ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b ANTAKYA STATE HOSPITAL   (Turkey)

Author keywords

cyclosporin; erdosteine; nephrotoxicity; protective effect

Indexed keywords

ALBUMIN; CATALASE; CREATININE; CYCLOSPORIN A; ERDOSTEINE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRIC OXIDE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; URIC ACID;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; MICROSCOPY; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; WISTAR ALBINO GLAXO RAT;

ANIMALS; ANTIOXIDANTS; CATALASE; CYCLOSPORINE; GLUTATHIONE PEROXIDASE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; MALE; MALONDIALDEHYDE; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOGLYCOLATES; THIOPHENES;

ANIMALIA; RATTUS;

EID: 84861830578     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327111417907     Document Type: Article

References (37)

1. Duru M, Nacar A, Yönden Z, et al. Protective effects of N-acetylcysteine on cyclosporine-A-induced nephrotoxicity. Ren Fail. 2008 ; 30: 453-459
2. Burman WA, Daemen AJ, Van der Linden CJ, Kootstra G.. Clinically used concentrations of cyclosporine A only partially inhibit interferon-gamma production by activated T lymphocytes. Transplant Proc. 1987 ; 19: 1193
3. Kang DH, Kim YG, Andoh TF, et al. Post-cyclosporine mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor. Am J Physiol Renal Physiol. 2001 ; 280: 727-736
4. Bobadilla NA, Tapia E, Jimenez F, et al. Dexamethasone increases eNOS gene expression and prevents renal vasoconstriction induced by cyclosporin. Am J Physiol. 1999 ; 277: 464-471
5. Binder AI, Graham EM, Sanders MD, et al. Cyclosporin A in the treatment of severe Behcet's uveitis. Br J Rheumatol. 1987 ; 26: 285-291
6. Lechevallier E, Dussol B, Luccioni A, et al. Posttransplantation acute tubular necrosis: risk factors and implications for graft survival. Am J Kidney Dis. 1998 ; 32: 984-991
7. Olyaei AJ, de Mattos AM, Bennett WM.. Immunosuppressant-induced nephropathy: Pathophysiology, incidence and management. Drug Saf. 1999 ; 21: 471-488
8. Burdmann EA, Andoh TF, Yu L, Bennett WM.. Cyclosporine nephrotoxicity. Semin Nephrol. 2003 ; 23: 465-476
9. Walker RJ, Lazzaro VA, Duggin GG, et al. Evidence that alterations in renal metabolism and lipid peroxidation may contribute to cyclosporine nephrotoxicity. Transplantation. 1990 ; 50: 487-492
10. Tariq M, Morais C, Sobki S, et al. N-Acetylcysteine attenuates cyclosporine-induced nephrotoxicity in rats. Nephrol Dial Transplant. 1999 ; 14: 923-929
11. Gazzani G, Fregnan GB, Vandoni G.. In vitro protection by erdosteine against oxidative inactivation of alpha-1-antitrypsin by cigarette smoke. Respiration. 1989 ; 55: 113-118
12. Fadillioglu E, Erdogan H, Sogut S, Kuku I.. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats. J Appl Toxicol. 2003 ; 23: 71-74
13. Oktem F, Arslan MK, Ozguner F, et al. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine. Toxicology. 2005 ; 215: 227-233
14. Ozyurt H, Yildirim Z, Kotuk M, et al. Cisplatin-induced acute renal failure is ameliorated by erdosteine in a dose-dependent manner. J Appl Toxicol. 2004 ; 24: 269-275
15. Yildirim Z, Sogut S, Odaci E, et al. Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats. Pharmacol Res. 2003 ; 47: 149-156
16. Yagmurca M, Fadillioglu E, Erdogan H, et al. Erdosteine prevents doxorubicin-induced cardiotoxicity in rats. Pharmacol Res. 2003 ; 48: 377-382
17. Isik B, Bayrak R, Akcay A, Sogut S.. Erdosteine against acetaminophen induced renal toxicity. Mol Cell Biochem. 2006 ; 287: 185-191
18. Turgut F, Carlioglu A, Alkan R, et al. The protective effect of erdostein on renal injury in diabetic rats. Turk Nephrol Dial Transplantation J. 2010 ; 19: 157-161
19. Sahin M, Cam H, Olgar S, et al. Protective role of erdosteine on vancomycin-induced oxidative stress in rat liver. Mol Cell Biochem. 2006 ; 291: 155-160
20. Esterbauer H, Cheeseman KH.. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990 ; 186: 407-421
21. Aebi H. Methods of enzymatic analysis. Bergmeyer HU, ed. New York and London: Academic Press ; 1974: 673-677.
22. Paglia DE, Valentine WN.. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967 ; 70: 158-169
23. Sun Y, Oberley LW, Li Y.. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988 ; 34: 497-500
24. Cortas NK, Wakid NW.. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-redion method. Clin Chem. 1990 ; 36: 1440-1443
25. Karahan I, Atessahin A, Yilmaz S, et al. Protective effect of lycopene on gentamicin-induced oxidative stress and nephrotoxicity in rats. Toxicology. 2005 ; 215: 198-204
26. Toosy N, Mcmorris ELJ, Grace PA, Mathie RT.. Ischaemic preconditioning protects the rat kidney from reperfusion injury. BJU Int. 1999 ; 84: 489-494
27. Parra T, de Arriba G, Conejo JR, et al. Cyclosporine increases local glomerular synthesis of reactive oxygen species in rats: effect of vitamin E on cyclosporine nephrotoxicity. Transplantation. 1998 ; 66: 1325-1329
28. Eşrefoglu M, Kurus M, Sahna E.. The beneficial effect of melatonin on chronic cyclosporin A nephrotoxicity in rats. J Int Med Res. 2003 ; 31: 42-44
29. Nacar A, Kiyici H, Ogus E, et al. Ultrastructural examination of glomerular and tubular changes in renal allografts with cyclosporine toxicity. Ren Fail. 2006 ; 28: 543-547
30. Sibley RK, Rynasiewicz J, Ferguson RM, et al. Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone. Surgery. 1983 ; 94: 225-234
31. Actis GC, Debernardi-Venon W, Lagget M, et al. Hepatotoxicity of intravenous cyclosporine A in patients with acute ulcerative colitis on total parenteral nutrition. Liver. 1995 ; 15: 320-323
32. Kim JY, Suh KS.. Light microscopic and electron microscopic features of cyclosporine nephrotoxicity in rats. J Korean Med Sci. 1995 ; 10: 352-359
33. Gokce A, Oktar S, Yonden Z, et al. Protective effect of caffeic acid phenethyl ester on cyclosporine A-induced nephrotoxicity in rats. Ren Fail. 2009 ; 31: 843-847
34. Peresleni T, Noiri E, Bahou WF, Goligorsky MS.. Antisense oligodeoxynucleotides to inducible NO synthase rescue epithelial cells from oxidative stress injury. Am J Physiol. 1996 ; 270: 971-977
35. Mohamadin AM, El-Beshbishy HA, El-Mahdy MA.. Green tea extract attenuates cyclosporine A-induced oxidative stress in rats. Pharmacol Res. 2005 ; 51: 51-57
36. Nishiyama A, Kobori H, Fukui T, et al. Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension. Hypertension. 2003 ; 42: 754-760
37. Selcoki Y, Uz E, Bayrak R, et al. The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats. Toxicology. 2007 ; 239: 53-59